Annual report pursuant to Section 13 and 15(d)

WARRANTS (Details Narrative)

v3.24.0.1
WARRANTS (Details Narrative) - USD ($)
 12 Months Ended
Mar. 06, 2024
Oct. 16, 2020
Jul. 28, 2020
Dec. 31, 2023
Dec. 31, 2022
Jan. 26, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Issuance of common stock upon exercise of stock options, shares       43,836    
Debt face amount       $ 16,303,738 $ 20,000,000  
Warrant [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Warrants to purchase shares of common stock, exercised       0 0  
Share-Based Payment Arrangement, Tranche One [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Debt face amount     $ 20,000,000      
CFF Warrant [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights           33,334
Exercise price of warrants           $ 396
Warrant exercisable price per share           $ 396
Investment Agreement [Member] | CFF Warrant [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights       50,207   33,334
Exercise price of warrants       $ 283.81    
Warrant exercisable price per share       $ 283.81    
Weighted average remaining life of warrants       1 year 7 months 6 days    
Warrant expire date       Jan. 26, 2025    
Fair Value Adjustment of Warrants       $ 6,215,225    
Loan Agreement [Member] | K2 HealthVentures LLC [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Exercise price of warrants     $ 208.8      
Warrants to purchase shares of common stock, exercised 142,857   2,873 194,444    
Warrant exercisable price per share     $ 208.8      
Loan Agreement [Member] | K2 Warrant [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     2,873      
Exercise price of warrants     $ 208.8      
Warrants to purchase shares of common stock, exercised     2,873      
Warrant exercisable price per share     $ 208.8      
Warrant expire date     Jul. 28, 2030      
Fair Value Adjustment of Warrants     $ 472,409      
Loan Agreement [Member] | K2 Warrant [Member] | Maximum [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Debt face amount     $ 50,000,000      
Professional Services Agreement [Member] | Warrants [Member] | Investor Relations Service Provider [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   14,000        
Exercise price of warrants   $ 32.1        
Warrant exercisable price per share   $ 32.1        
Fair Value Adjustment of Warrants   $ 334,740